These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22413798)

  • 1. Challenges obtaining a biowaiver for topical veterinary dosage forms.
    Baynes R; Riviere J; Franz T; Monteiro-Riviere N; Lehman P; Peyrou M; Toutain PL
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():103-14. PubMed ID: 22413798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current challenges facing the determination of product bioequivalence in veterinary medicine.
    Martinez MN; Hunter RP
    J Vet Pharmacol Ther; 2010 Oct; 33(5):418-33. PubMed ID: 20840385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations for extrapolating in vivo bioequivalence data across species and routes.
    Modric S; Bermingham E; Heit M; Lainesse C; Thompson C
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():45-52. PubMed ID: 22413791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges associated with the demonstration of bioequivalence of intramammary products in ruminants.
    Lainesse C; Gehring R; Pasloske K; Smith G; Soback S; Wagner S; Whittem T
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():65-79. PubMed ID: 22413793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating product bioequivalence for highly variable veterinary drugs.
    Claxton R; Cook J; Endrenyi L; Lucas A; Martinez MN; Sutton SC
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():11-6. PubMed ID: 22413787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioequivalence accomplishments, ongoing initiatives, and remaining challenges.
    Martinez MN
    J Vet Pharmacol Ther; 2014 Feb; 37(1):2-12. PubMed ID: 23841644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges associated with the evaluation of veterinary product bioequivalence: an AAVPT perspective.
    Martinez M; Langston C; Martin T; Conner D
    J Vet Pharmacol Ther; 2002 Jun; 25(3):201-20. PubMed ID: 12081616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Getting the right drug at the right dosage. Personalized medicine brings precision to drug treatment.
    AVMA Group Health and Life Insurance Trust
    J Am Vet Med Assoc; 2008 Oct; 233(8):1212-3. PubMed ID: 19180707
    [No Abstract]   [Full Text] [Related]  

  • 9. The 2010 AAVPT/EAVPT/ECVPT bioequivalence workshop.
    Martinez M; Hunter RP; Baynes R; Bermingham E; Claxton R; Cole C; Del Castillo J; Gehring R; Harshman K; Lainesse C; Lucas A; Modric S; Robinson J
    J Vet Pharmacol Ther; 2011 Apr; 34(2):105-7. PubMed ID: 21395599
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug solubility classification in the bovine.
    Martinez MN; Apley MD
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():93-7. PubMed ID: 22413796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residue avoidance after topical application of veterinary drugs and parasiticides.
    Baynes RE; Craigmill AL; Riviere JE
    J Am Vet Med Assoc; 1997 May; 210(9):1288-9. PubMed ID: 9143531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissolution test development for complex veterinary dosage forms: oral boluses.
    Fahmy R; Marnane B; Bensley D; Hollenbeck RG
    AAPS PharmSci; 2002; 4(4):E35. PubMed ID: 12646007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination.
    Lees P; Hunter RP; Reeves PT; Toutain PL
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():17-29. PubMed ID: 22413788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug solubility classification in the dog.
    Martinez MN; Papich MG
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():87-91. PubMed ID: 22413795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International veterinary bioequivalence guideline similarities and differences between Australia, Canada, Europe, Japan, New Zealand and the United States.
    Lainesse C
    AAPS J; 2012 Dec; 14(4):792-8. PubMed ID: 22864669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing bioequivalence of veterinary premixes (Type A medicated articles).
    Hunter RP; Lees P; Concordet D; Toutain PL
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():53-63. PubMed ID: 22413792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current update on drugs for game bird species.
    Needham ML; Webb AI; Baynes RE; Riviere JE; Craigmill AL; Tell LA
    J Am Vet Med Assoc; 2007 Nov; 231(10):1506-8. PubMed ID: 18020991
    [No Abstract]   [Full Text] [Related]  

  • 18. Biodegradable polymers and their potential use in parenteral veterinary drug delivery systems.
    Winzenburg G; Schmidt C; Fuchs S; Kissel T
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1453-66. PubMed ID: 15191792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and opportunities in animal drug development: a regulatory perspective.
    Lathers CM
    Nat Rev Drug Discov; 2003 Nov; 2(11):915-8. PubMed ID: 14560318
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioavailability of veterinary drugs in vivo and in silico.
    Grabowski T; Jaroszewski JJ
    J Vet Pharmacol Ther; 2009 Jun; 32(3):249-57. PubMed ID: 19646089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.